Theaflavin (Black Tea Polyphenol · Cholesterol-Lowering · Cardiovascular)

Compound	Theaflavin (TF1)
Chemical class	Polyphenol — Theaflavin (Black tea oxidation product)
CAS	4670-05-7
Primary source	Camellia sinensis (fermented/oxidised leaves — black tea)
Key applications	Cholesterol-lowering, cardiovascular, antioxidant
Claim strength	Moderate
Typical form	Black tea extract standardised to theaflavin content; isolated theaflavin

Name origin: From tea + flavin (reflecting the yellow-orange pigmentation these compounds impart to black tea liquor). Theaflavins are formed during black tea fermentation (oxidation) when two catechin units condense via enzymatic oxidation to form the characteristic benzotropolone ring system. TF1 (theaflavin) is the simplest and most studied; TF2a, TF2b (theaflavin monogallates), and TF3 (theaflavin-3,3’-digallate) are co-present in black tea. Traditional use: Black tea has been consumed globally for centuries with assumed cardiovascular and digestive benefits. Theaflavins are the primary bioactives distinguishing black tea’s pharmacology from green tea’s catechin-dominated profile. Research trajectory: Theaflavins have a meaningful clinical evidence base for LDL cholesterol reduction, with several human RCTs. Evidence quality is moderate; black tea extract rather than isolated theaflavin is the most commonly studied format. Commercial source: Theaflavin-standardised black tea extracts are available; Herbuno does not currently carry a dedicated theaflavin extract (product-pending).

---

Evidence for Theaflavin Applications

LDL cholesterol reduction: Several human RCTs using theaflavin-enriched green tea extract (a hybrid product delivering theaflavins) or black tea extract show significant reductions in LDL-C (5–11%) and total cholesterol over 12 weeks. Mechanisms include HMG-CoA reductase inhibition and bile acid sequestration. A well-designed RCT published in the Archives of Internal Medicine demonstrated 16.4% LDL reduction with a theaflavin-enriched supplement. Claim strength: Moderate.

Antioxidant and anti-inflammatory: Theaflavins have potent antioxidant activity, with the benzotropolone ring system contributing to radical-scavenging capacity comparable to or exceeding EGCG on a molar basis. Anti-inflammatory effects via NF-κB suppression and COX-2 inhibition are documented in cell models. Claim strength: Moderate.

Antiviral activity: In vitro studies show theaflavins inhibit influenza neuraminidase, HIV-1 reverse transcriptase, and SARS-CoV-2 protease. Theaflavin-3-gallate and digallate forms are more potent than TF1 in antiviral assays. Clinical antiviral translation is absent. Claim strength: Emerging.

---

Dosage & Formulator Specification

LDL-lowering RCTs: 75–150 mg/day theaflavin equivalent, as theaflavin-standardised extract, taken with meals. The landmark LDL-reduction study used 375 mg/day of a theaflavin-enriched supplement. For general cardiovascular antioxidant support, black tea extract standardised to 20–40% theaflavins at 200–400 mg/day is a working range.

Specify theaflavin content by HPLC, with individual reporting of TF1, TF2a, TF2b, and TF3 (the gallated forms have higher potency for most mechanisms). Some suppliers offer theaflavin-3,3’-digallate-enriched extracts for premium applications.

Theaflavins are water-soluble and reasonably bioavailable. They are stable under acidic conditions and heat-processing temperatures. Bioavailability is lower than epicatechin monomers but better than larger condensed tannins. Co-formulation with phospholipids may improve absorption.

---

Frequently Asked Questions — Theaflavin

How do theaflavins differ from green tea catechins?
Theaflavins are formed by enzymatic oxidative condensation of two catechin units during black tea fermentation. They are larger, more complex molecules with a characteristic benzotropolone ring system absent in catechins. Theaflavins are specific to fermented teas (black, oolong); green tea does not contain them. Their bioavailability profile differs from catechins and their primary evidence base is cardiovascular (cholesterol) rather than metabolic (weight).

Is theaflavin or theaflavin digallate the preferred form?
Theaflavin-3,3’-digallate (TF3) shows greater potency than TF1 in most in vitro assays due to the additional gallate groups. For maximum LDL-lowering and antiviral activity, a theaflavin extract rich in gallated forms (TF2a + TF2b + TF3) is preferred over TF1-dominant extracts. Request a full theaflavin profile CoA when sourcing.

Can theaflavins be positioned as a black tea equivalent to green tea’s EGCG?
Functionally, yes — theaflavins are the primary polyphenol differentiator of black tea versus green tea. For cardiovascular claims, theaflavins have comparable or stronger clinical evidence than EGCG specifically. For metabolic/weight management claims, EGCG remains better supported. A combination of green tea catechins and black tea theaflavins provides complementary polyphenol coverage.

Does milk added to black tea reduce theaflavin bioactivity?
Milk proteins (particularly casein) bind to theaflavins and catechins, reducing their antioxidant activity in vitro and potentially reducing bioavailability. Human studies on this question are mixed — some show reduced vascular effects with milk addition, others do not. For supplement formulations, this is not relevant (theaflavin is in capsule/tablet form), but it is useful context for functional beverage positioning.

---

Claim-strength scale – High = multiple human RCTs; Moderate = limited trials or strong preclinical convergence; Emerging = early-stage lab or animal data.

← HerbIQ Compound Index · HerbIQ P02: Extraction · HerbIQ P03: Delivery